ConvaTec Group (LON:CTEC – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Berenberg Bank in a research report issued on Wednesday, Digital Look reports. They presently have a GBX 290 ($3.56) target price on the stock. Berenberg Bank’s price objective would indicate a potential upside of 31.10% from the company’s current price.
Several other equities research analysts have also recently issued reports on the company. Barclays reaffirmed an “overweight” rating and issued a GBX 310 ($3.81) target price on shares of ConvaTec Group in a report on Wednesday, September 6th. Royal Bank of Canada raised ConvaTec Group to an “outperform” rating and upped their price objective for the stock from GBX 215 ($2.64) to GBX 300 ($3.68) in a report on Thursday, September 7th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 300 ($3.68) target price on shares of ConvaTec Group in a report on Wednesday. Finally, The Goldman Sachs Group started coverage on shares of ConvaTec Group in a research note on Tuesday, September 5th. They set a “buy” rating and a GBX 300 ($3.68) price target on the stock. Six analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of GBX 298.33 ($3.66).
ConvaTec Group Stock Performance
ConvaTec Group Company Profile
ConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
- Five stocks we like better than ConvaTec Group
- Dividend Payout Ratio Calculator
- Buffett’s latest portfolio additions, trims, and cuts in Q3
- Market Cap Calculator: How to Calculate Market Cap
- 5 reasons TJX Companies will hit new highs in 2024
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Game-changing news for Ambarella puts the market in reversal
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.